
Sign up to save your podcasts
Or


Send us Fan Mail
Summary:
This podcast addresses the overlap seen in depression and psychosis, and how the second generation antipsychotic meds have expanding FDA-approved indications.
Topics:
· This little light of mine 01:10
· Advertising through you 02:20
· Dopamine 04:00
· Homeostasis-Balance 04:50
· Participate & Communicate 07:00
· Decreased Dopamine 08:15
- Parkinsons
- Restless Leg Syndrome
· Dopamine Receptors
· Increased Dopamine 12:00
- Schizophrenia
· 1st and 2nd Generation Antipsychotics 14:00
· Side Effects 14:40
· Risk-Benefit 15:20
· Extrapyramidal Symptoms 16:15
· Relapse decrease with Caplyta 17:30
· Internet Gaming Disorder 20:00
· Caplyte 25:15
· 5 Steps of Drug Development 28:00
Questions and comments to [email protected]
By Donald Schoeff R.Ph.3.7
33 ratings
Send us Fan Mail
Summary:
This podcast addresses the overlap seen in depression and psychosis, and how the second generation antipsychotic meds have expanding FDA-approved indications.
Topics:
· This little light of mine 01:10
· Advertising through you 02:20
· Dopamine 04:00
· Homeostasis-Balance 04:50
· Participate & Communicate 07:00
· Decreased Dopamine 08:15
- Parkinsons
- Restless Leg Syndrome
· Dopamine Receptors
· Increased Dopamine 12:00
- Schizophrenia
· 1st and 2nd Generation Antipsychotics 14:00
· Side Effects 14:40
· Risk-Benefit 15:20
· Extrapyramidal Symptoms 16:15
· Relapse decrease with Caplyta 17:30
· Internet Gaming Disorder 20:00
· Caplyte 25:15
· 5 Steps of Drug Development 28:00
Questions and comments to [email protected]

155 Listeners